Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

Serotonergic hallucinogens produce profound changes in perception, mood, and cognition. These drugs include phenylalkylamines such as mescaline and 2,5-dimethoxy-4-methylamphetamine (DOM), and indoleamines such as (+)-lysergic acid diethylamide (LSD) and psilocybin. Despite their differences in chemical structure, the two classes of hallucinogens produce remarkably similar subjective effects in humans, and induce cross-tolerance. The phenylalkylamine hallucinogens are selective 5-HT(2) receptor agonists, whereas the indoleamines are relatively non-selective for serotonin (5-HT) receptors. There is extensive evidence, from both animal and human studies, that the characteristic effects of hallucinogens are mediated by interactions with the 5-HT(2A) receptor. Nevertheless, there is also evidence that interactions with other receptor sites contribute to the psychopharmacological and behavioral effects of the indoleamine hallucinogens. This article reviews the evidence demonstrating that the effects of indoleamine hallucinogens in a variety of animal behavioral paradigms are mediated by both 5-HT(2) and non-5-HT(2) receptors.

[1]  R. Glennon,et al.  Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding. , 1998, Journal of medicinal chemistry.

[2]  R. Strassman,et al.  Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. , 1994, Archives of general psychiatry.

[3]  F. Nagai,et al.  The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. , 2007, European journal of pharmacology.

[4]  M. Geyer,et al.  Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats , 2005, Psychopharmacology.

[5]  T. Yamamoto,et al.  Behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rats and mice. , 1975, European journal of pharmacology.

[6]  D. Marona-Lewicka,et al.  Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI , 2009, Psychopharmacology.

[7]  D. Airey,et al.  The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen , 2010, Psychopharmacology.

[8]  W. Foote,et al.  Action of psychotogenic drugs on single midbrain raphe neurons. , 1970, The Journal of pharmacology and experimental therapeutics.

[9]  M. Spitzer,et al.  Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: Experimental psychosis as a tool for psychiatric research , 1992, Biological Psychiatry.

[10]  M. Geyer,et al.  5-HT2A and 5-HT2C receptors exert opposing effects on locomotor activity in mice , 2009, Neuropsychopharmacology.

[11]  M. Millan,et al.  Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes , 2002, Journal of Pharmacology and Experimental Therapeutics.

[12]  M. Fekete,et al.  ANTIMESCALINE PROPERTIES OF SOME LYSERGIC ACID DERIVATIVES. , 1963, International journal of neuropharmacology.

[13]  W. Potter,et al.  Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[14]  B. Jacobs,et al.  Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats , 1981, Brain Research.

[15]  Stuart C. Sealfon,et al.  Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior , 2007, Neuron.

[16]  S. Gershon,et al.  Delirium: a subcortical phenomenon? , 1989 .

[17]  C. Nemeroff,et al.  The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration. , 1991, The Journal of pharmacology and experimental therapeutics.

[18]  Alexander T. Shulgin,et al.  Tihkal : The Continuation , 1997 .

[19]  A. S. Kulkarni.  Scratching response induced in mice by mescaline and related amphetamine derivatives. , 1973, Biological psychiatry.

[20]  G. Kennett,et al.  Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists. , 2001, Pharmacology, biochemistry, and behavior.

[21]  M. Geyer,et al.  Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors , 2008, Psychopharmacology.

[22]  M. D. Zimmerman,et al.  The stimulus properties of LSD in C57BL/6 mice , 2005, Pharmacology Biochemistry and Behavior.

[23]  J. Horáček,et al.  Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose , 2007, Psychopharmacology.

[24]  K. Rice,et al.  Discriminative Stimulus Effects of 1-( 2 , 5-Dimethoxy-4-Methylphenyl )-2-Aminopropane in Rhesus Monkeys : Antagonism and Apparent p A 2 Analyses , 2009 .

[25]  G. Chen,et al.  A study of certain CNS depressants. , 1960, Archives internationales de pharmacodynamie et de therapie.

[26]  D. Woolley,et al.  A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS. , 1954, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Glennon,et al.  Hallucinogens and serotonergic mechanisms. , 1992, NIDA research monograph.

[28]  D. Airey,et al.  5-HT2C receptor RNA editing in the amygdala of C57BL/6J, DBA/2J, and BALB/cJ mice , 2006, Neuroscience Research.

[29]  J. C. Winter,et al.  Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents , 2008, Pharmacology Biochemistry and Behavior.

[30]  M. Geyer,et al.  Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol , 2006, Psychopharmacology.

[31]  Barry L. Jacobs,et al.  Handbook of the behavioral neurobiology of serotonin , 2010 .

[32]  G. Aghajanian,et al.  Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists , 1987, Synapse.

[33]  J. Arnt.  Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats. , 1989, Pharmacology & toxicology.

[34]  J. C. Winter,et al.  Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli , 2004, Psychopharmacologia.

[35]  M. Trulson.  Dissociations between the effects of hallucinogens on behavior and raphe unit activity in behaving cats , 1986, Pharmacology Biochemistry and Behavior.

[36]  R. Kellner,et al.  Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. , 1994, Archives of general psychiatry.

[37]  S. Snyder,et al.  Two distinct central serotonin receptors with different physiological functions. , 1981, Science.

[38]  M. Asanuma,et al.  5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter. , 2007, Toxicology letters.

[39]  J. C. Winter,et al.  Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats , 2006, Pharmacology Biochemistry and Behavior.

[40]  Antoni Rodríguez-Fornells,et al.  Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively , 2002, Psychopharmacology.

[41]  M. Pompeiano,et al.  Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  C. Grob,et al.  Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. , 2011, Archives of general psychiatry.

[43]  B. Jacobs,et al.  Alterations of serotonin and LSD receptor binding following repeated administration of LSD. , 1979, Life sciences.

[44]  A. Sleight,et al.  5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. , 1998, The Journal of pharmacology and experimental therapeutics.

[45]  R. Thisted,et al.  Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis , 2005, Psychopharmacology.

[46]  N. Darmani,et al.  The mechanism by which the selective 5-HT1A receptor antagonist S-(−)UH 301 produces head-twitches in mice , 1996, Pharmacology Biochemistry and Behavior.

[47]  M. Geyer,et al.  A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats. , 1985, Behavioral neuroscience.

[48]  T. Sharp,et al.  Further pharmacological characterization of 5‐HT2C receptor agonist‐induced inhibition of 5‐HT neuronal activity in the dorsal raphe nucleus in vivo , 2009, British journal of pharmacology.

[49]  G. Aghajanian,et al.  Serotonin: From Cell Biology to Pharmacology and Therapeutics , 2011 .

[50]  J. Leysen,et al.  Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells. , 1993, Biochemical pharmacology.

[51]  S. Peroutka,et al.  Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors. , 1991, Biochemical pharmacology.

[52]  C. de Montigny,et al.  Effect of Pindolol on the Function of Pre- and Postsynaptic 5-HT1A Receptors: In Vivo Microdialysis and Electrophysiological Studies in the Rat Brain , 1996, Neuropsychopharmacology.

[53]  K. Rice,et al.  Discriminative Stimulus Effects of 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane in Rhesus Monkeys , 2008, Journal of Pharmacology and Experimental Therapeutics.

[54]  P. Cowen,et al.  Serotonin, sleep and mental disorder , 1991 .

[55]  F. Colpaert.  Cross generalization with LSD and yohimbine in the rat. , 1984, European journal of pharmacology.

[56]  M. Geyer,et al.  Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats , 1994, Neuropharmacology.

[57]  A. Shulgin,et al.  PIHKAL: A Chemical Love Story , 1991 .

[58]  F. J. White,et al.  The discriminative stimulus properties of LSD: Mechanisms of action , 1978, Neuropharmacology.

[59]  R. Griffiths,et al.  Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance , 2006, Psychopharmacology.

[60]  H. Meltzer,et al.  Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. , 1997, The Journal of pharmacology and experimental therapeutics.

[61]  J. B. Appel,et al.  Increasing the Selectivity of Drug Discrimination Procedures , 1999, Pharmacology Biochemistry and Behavior.

[62]  David C. Burr,et al.  Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors , 2005, Journal of Cognitive Neuroscience.

[63]  M. Geyer,et al.  Serotonin1B Receptor Activation Mimics Behavioral Effects of Presynaptic Serotonin Release , 1993, Neuropsychopharmacology.

[64]  R. Glennon.  Do classical hallucinogens act as 5-HT2 agonists or antagonists? , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[65]  A. Balestrieri,et al.  Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148. , 1959, A.M.A. archives of general psychiatry.

[66]  J. C. Winter,et al.  Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli , 2004, Psychopharmacology.

[67]  R. Glennon,et al.  Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis , 1989, Psychopharmacology.

[68]  T. Meert,et al.  Pharmacological validation of ritanserin and risperidone in the drug discrimination test procedure in the rat , 1990 .

[69]  M. Geyer,et al.  Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens , 2004, Psychopharmacology.

[70]  F. Colpaert,et al.  Transduction Mechanisms of Drug Stimuli , 1988, Psychopharmacology Series.

[71]  G. Koob,et al.  A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA , 2004, Psychopharmacology.

[72]  N. Darmani.  The silent and selective 5-HT1A antagonist, WAY 100635, produces via an indirect mechanism, a 5-HT2A receptor-mediated behaviour in mice during the day but not at night , 1998, Journal of Neural Transmission.

[73]  Michael R. Braden,et al.  1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists. , 2006, Journal of medicinal chemistry.

[74]  R. Schultes,et al.  The Botany and Chemistry of Hallucinogens , 1974 .

[75]  M. Geyer,et al.  A characteristic effect of hallucinogens on investigatory responding in rats , 1979, Psychopharmacology.

[76]  M. Geyer,et al.  Knockout Mice Reveal Opposite Roles for Serotonin 1A and 1B Receptors in Prepulse Inhibition , 2000, Neuropsychopharmacology.

[77]  R. Brimblecombe.  Effects of psychotropic drugs on open-field behaviour in rats , 1963, Psychopharmacologia.

[78]  M. Low,et al.  Differential Contributions of Dopamine D1, D2, and D3 Receptors to MDMA-Induced Effects on Locomotor Behavior Patterns in Mice , 2006, Neuropsychopharmacology.

[79]  T. Meert,et al.  Behavioral and 5-HT antagonist effects of ritanserin: A pure and selective antagonist of LSD discrimination in rat , 2004, Psychopharmacology.

[80]  D. Marona-Lewicka,et al.  Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action , 2007, Pharmacology Biochemistry and Behavior.

[81]  J. Barrett,et al.  WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Preclinical Antipsychotic-Like Activity , 2007, Journal of Pharmacology and Experimental Therapeutics.

[82]  J. C. Winter,et al.  Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats , 2005, Psychopharmacology.

[83]  R. Glennon,et al.  Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist. , 1993, Journal of medicinal chemistry.

[84]  R. Glennon.  Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH DPAT) , 1986, Pharmacology Biochemistry and Behavior.

[85]  J. Palacios,et al.  [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding , 1986, Neuroscience Letters.

[86]  R. S. Sloviter,et al.  Specificity of a rat behavioral model for serotonin receptor activation. , 1978, The Journal of pharmacology and experimental therapeutics.

[87]  J. Kabeš,et al.  A new device for measuring spontaneous motor activity — Effects of lysergic acid diethylamide in rats , 2004, Psychopharmacologia.

[88]  M. Geyer,et al.  Persistent effects of chronic administration of LSD on intracellular serotonin content in rat midbrain , 1980, Neuropharmacology.

[89]  D. Hoyer.  Molecular pharmacology and biology of 5-HT1C receptors. , 1988, Trends in pharmacological sciences.

[90]  R. Glennon,et al.  Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[91]  J. Fozard,et al.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. , 1984, European journal of pharmacology.

[92]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[93]  Patrick V. Russo,et al.  Multivariate assessment of locomotor behavior: Pharmacological and behavioral analyses , 1986, Pharmacology Biochemistry and Behavior.

[94]  D. E. Nichols,et al.  Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes. , 1995, Journal of medicinal chemistry.

[95]  W. Foote,et al.  Lysergic Acid Diethylamide: Sensitive Neuronal Units in the Midbrain Raphe , 1968, Science.

[96]  M. Geyer,et al.  Multivariate and nonlinear approaches to characterizing drug effects on the locomotor and investigatory behavior of rats. , 1992, NIDA research monograph.

[97]  J. Palacios,et al.  The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. , 1984, European journal of pharmacology.

[98]  R. Glennon,et al.  Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions , 1990, Pharmacology Biochemistry and Behavior.

[99]  G. Aghajanian,et al.  Response of single raphé neurons to (+)‐LSD: correlation with (+)‐LSD binding in brain , 1976, The Journal of pharmacy and pharmacology.

[100]  D. Marona-Lewicka,et al.  Complex stimulus properties of LSD: a drug discrimination study with α2-adrenoceptor agonists and antagonists , 1995, Psychopharmacology.

[101]  J. C. Winter,et al.  The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis , 1995, Psychopharmacology.

[102]  M. Pranzatelli,et al.  Quantitative autoradiography of 5-hydroxytryptamine1A binding sites in rats with chronic neonatal 5,7-dihydroxytryptamine lesions. , 1994, Brain research. Developmental brain research.

[103]  M. Geyer,et al.  The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[104]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[105]  M. Titeler,et al.  Detection and Characterization of the Serotonin 5‐HT1D Receptor in Rat and Human Brain , 1988 .

[106]  A. Green.  Neuropharmacology of serotonin , 1985 .

[107]  J. C. Winter,et al.  Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines , 2009, Psychopharmacology.

[108]  D. Minnema,et al.  Amphetamine and LSD as discriminative stimuli: Alterations following neonatal monoamine reductions , 1984, Pharmacology Biochemistry and Behavior.

[109]  M A Geyer,et al.  Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats. , 1999, The Journal of pharmacology and experimental therapeutics.

[110]  S. Peroutka,et al.  Pharmacological Differentiation and Characterization of 5‐HT1A, 5‐HT1B, and 5‐HT1C Binding Sites in Rat Frontal Cortex , 1986, Journal of neurochemistry.

[111]  R. Mailman,et al.  LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors , 1995, Psychopharmacology.

[112]  D. E. Nichols,et al.  Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats , 2002, Psychopharmacology.

[113]  H. Steinbusch,et al.  Hypomobility after DOI administration can be reversed by subthalamic nucleus deep brain stimulation , 2007, Behavioural Brain Research.

[114]  S. Snyder,et al.  2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug , 1967, Science.

[115]  B. Jacobs,et al.  Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD. , 1976, Psychopharmacology communications.

[116]  R. Strassman.  DMT: The Spirit Molecule: A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences , 2000 .

[117]  Franz X Vollenweider,et al.  The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval , 2007, Neuropsychopharmacology.

[118]  M. Geyer,et al.  5HT-2 mediation of acute behavioral effects of hallucinogens in rats , 2005, Psychopharmacology.

[119]  C. P. Vandermaelen,et al.  Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. , 1986, European journal of pharmacology.

[120]  R. Strassman.  Human psychopharmacology of N,N-dimethyltryptamine , 1995, Behavioural Brain Research.

[121]  C. Anderson,et al.  Lorcaserin (APD356), a Selective 5‐HT2C Agonist, Reduces Body Weight in Obese Men and Women , 2009, Obesity.

[122]  M. Peet,et al.  Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague–Dawley rats , 2010, Pharmacology Biochemistry and Behavior.

[123]  F. Yocca,et al.  Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. , 1992, Molecular pharmacology.

[124]  S. Peroutka,et al.  Differential effects of 5-hydroxytryptamine1A selective drugs on the 5-HT behavioral syndrome , 1986, Pharmacology Biochemistry and Behavior.

[125]  Andreas Bäbler,et al.  Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action , 1998, Neuroreport.

[126]  J. C. Winter.  Yohimbine-induced stimulus control in the rat. , 1978, Archives internationales de pharmacodynamie et de therapie.

[127]  J. C. Winter.  Generalization of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone to yohimbine , 1988, Pharmacology Biochemistry and Behavior.

[128]  Klaus-Peter Ossenkopp,et al.  Measuring Movement and Locomotion: From Invertebrates to Humans , 1996 .

[129]  H. Calil,et al.  Screening hallucinogenic drugs: Systematic study of three behavioral tests , 1975, Psychopharmacologia.

[130]  E. sanders-Bush,et al.  Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. , 1988, The Journal of pharmacology and experimental therapeutics.

[131]  P. Seeman,et al.  Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil , 2009, Synapse.

[132]  L. Hollister,et al.  An hallucinogenic amphetamine analog (DOM) in man , 2004, Psychopharmacologia.

[133]  E. sanders-Bush,et al.  Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(±)DOI] in C57BL/6J mice , 2003, Psychopharmacology.

[134]  Glennon Ra.  Discriminative stimulus properties of hallucinogens and related designer drugs. , 1991 .

[135]  J. Saavedra,et al.  Chronic treatment with (+/-)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain. , 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[136]  J. C. Winter,et al.  Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. , 1992, The Journal of pharmacology and experimental therapeutics.

[137]  H. Abramson,et al.  Production of Cross-Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide and Psilocybin , 1960 .

[138]  Sipes Te,et al.  DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT(2A) and not by 5-HT(2C) receptors. , 1995 .

[139]  R. Glennon,et al.  Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. , 1984, Life sciences.

[140]  A. S. Eison,et al.  5-HT1A and 5-HT2 receptors mediate discrete behaviors in the Mongolian Gerbil , 1992, Pharmacology Biochemistry and Behavior.

[141]  M. Geyer,et al.  Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats , 1991, Neuropharmacology.

[142]  R. Porter,et al.  Functional characterization of agonists at recombinant human 5‐HT2A, 5‐HT2B and 5‐HT2C receptors in CHO‐K1 cells , 1999, British journal of pharmacology.

[143]  D. Marona-Lewicka,et al.  Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives , 1994, Pharmacology Biochemistry and Behavior.

[144]  J. C. Winter,et al.  The 5-HT1A receptor and the stimulus effects of LSD in the rat , 2005, Psychopharmacology.

[145]  B. Ho,et al.  Role of serotonin in the discriminative stimulus properties of mescaline , 1975, Pharmacology Biochemistry and Behavior.

[146]  C. Pycock,et al.  ‘Wet-Dog’ shake behaviour in the rat: A possible quantitative model of central 5-hydroxytryptamine activity , 1977, Neuropharmacology.

[147]  S. Peroutka,et al.  Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex , 2004, Psychopharmacology.

[148]  J. Leysen,et al.  Gaps and peculiarities in 5-HT2 receptor studies. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[149]  A. Grottick,et al.  Effect of LSD on Prepulse Inhibition and Spontaneous Behavior in the Rat: A Pharmacological Analysis and Comparison between Two Rat Strains , 2001, Neuropsychopharmacology.

[150]  Michael Kometer,et al.  The neurobiology of psychedelic drugs: implications for the treatment of mood disorders , 2010, Nature Reviews Neuroscience.

[151]  D. Spencer,et al.  The interoceptive discriminative stimuli induced by the novel putative anxiolytic TVX Q 7821: behavioral evidence for the specific involvement of serotonin 5-HT1A receptors , 2004, Psychopharmacology.

[152]  B. Jacobs,et al.  Some behavioral effects of hallucinogens are mediated by a postsynaptic serotonergic action: evidence from single unit studies in freely moving cats. , 1984, European journal of pharmacology.

[153]  F. J. White,et al.  Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions. , 1982, Science.

[154]  B. Jacobs,et al.  Electrophysiological evidence against negative neuronal feedback from the forebrain controlling midbrain raphe unit activity , 1977, Brain Research.

[155]  Kulkarni As.  Scratching response induced in mice by mescaline and related amphetamine derivatives. , 1973 .

[156]  W. Herrmann,et al.  Clinical Effectiveness of Lisuride Hydrogen Maleate: A Double‐Blind Trial Versus Methysergide , 1977, Headache.

[157]  H. Isbell.  Comparison of the reactions induced by psilocybin and LSD-25 in man , 2004, Psychopharmacologia.

[158]  I. Lucki,et al.  Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. , 1984, The Journal of pharmacology and experimental therapeutics.

[159]  C. Niemegeers,et al.  A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist. , 1982, The Journal of pharmacology and experimental therapeutics.

[160]  D. E. Nichols,et al.  Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines. , 2001 .

[161]  K. Rice,et al.  Interaction of 5-HT2A and 5-HT2C Receptors in R(−)-2,5-Dimethoxy-4-iodoamphetamine-Elicited Head Twitch Behavior in Mice , 2010, Journal of Pharmacology and Experimental Therapeutics.

[162]  R. Emeson,et al.  Regulation of serotonin-2C receptor G-protein coupling by RNA editing , 1997, Nature.

[163]  J. C. Winter,et al.  5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects ofm-chlorophenylpiperazine , 1995, Psychopharmacology.

[164]  M. Geyer,et al.  Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis , 2007, Journal of psychopharmacology.

[165]  M. Geyer,et al.  Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans , 1998, Behavioural pharmacology.

[166]  E. sanders-Bush.  Neurochemical evidence that hallucinogenic drugs are 5-HT1c receptor agonists: what next? , 1994, NIDA research monograph.

[167]  R. Schreiber,et al.  Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. , 1994, European journal of pharmacology.

[168]  H. Berendsen,et al.  Selective activation of 5HT1A receptors induces lower lip retraction in the rat , 1989, Pharmacology Biochemistry and Behavior.

[169]  J. C. Winter,et al.  Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs II: reassessment of LSD false positives , 1995, Psychopharmacology.

[170]  D. Nichols.  Role of Serotoninergic Neurons and 5-HT Receptors in the Action of Hallucinogens , 2000 .

[171]  Hallucinogens, neurochemical, behavioral, and clinical perspectives , 1984 .

[172]  H. Isbell,et al.  Comparison of psilocin with psilocybin, mescaline and LSD-25 , 2004, Psychopharmacologia.

[173]  B. Jacobs,et al.  Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats. , 1994, The Journal of pharmacology and experimental therapeutics.

[174]  M. De Vivo,et al.  Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. , 1986, The Journal of pharmacology and experimental therapeutics.

[175]  M. Geyer,et al.  Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. , 1990, The Journal of pharmacology and experimental therapeutics.

[176]  M. Geyer,et al.  5‐HT1B Receptor Modulation of Prepulse Inhibition: Recent Findings in Wild‐type and 5‐HT1B Knockout Mice a , 1998, Annals of the New York Academy of Sciences.

[177]  P. Hartig,et al.  125I-lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[178]  M. Low,et al.  Differential Effects of Direct and Indirect Dopamine Agonists on Prepulse Inhibition: A Study in D1 and D2 Receptor Knock-Out Mice , 2002, The Journal of Neuroscience.

[179]  H. Isbell,et al.  Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions , 1962, Psychopharmacologia.

[180]  F. Vollenweider,et al.  Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis , 1997, Neuropsychopharmacology.

[181]  N. Weissman,et al.  Multicenter, placebo-controlled trial of lorcaserin for weight management. , 2010, The New England journal of medicine.

[182]  C. Montigny,et al.  Electrophysiologically-identified serotonin receptors in the rat CNS Effect of antidepressant treatment , 1984, Neuropharmacology.

[183]  H. Berendsen,et al.  Role of dorsal and median raphe nuclei in lower lip retraction in rats. , 1994, European journal of pharmacology.

[184]  R. Glennon,et al.  Iodine-125 labeled 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors , 1988 .

[185]  N. Newberry,et al.  Characterisation of Human 5‐Hydroxytryptamine2A and 5‐Hydroxytryptamine2C Receptors Expressed in the Human Neuroblastoma Cell Line SH‐SY5Y: Comparative Stimulation by Hallucinogenic Drugs , 1996, Journal of neurochemistry.

[186]  M. Geyer,et al.  DOI disruption of prepulse inhibition of startle in the rat is mediated by 5‐HT2A and not by 5‐HT2C receptors , 1995, Behavioural pharmacology.

[187]  G. Kennett,et al.  Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by 5-HT2C receptor agonists , 2001, Pharmacology Biochemistry and Behavior.

[188]  J. Leysen,et al.  [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.

[189]  E. Russo,et al.  Binding Properties of Dipropyltryptamine at the Human 5-HT1a Receptor , 2005, Pharmacology.

[190]  C. Montigny,et al.  Electrophysiology of Central Serotonin Neurotransmission , 1993 .

[191]  R. Glennon,et al.  Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens , 2004, Psychopharmacology.

[192]  R. Glennon,et al.  Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines. , 1994, Journal of medicinal chemistry.

[193]  R. Glennon.  Site-selective serotonin agonists as discriminative stimuli. , 1988, Psychopharmacology series.

[194]  A. Wikler,et al.  Cross tolerance between LSD and psilocybin , 2004, Psychopharmacologia.

[195]  S. Corne,et al.  A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. , 1963, British journal of pharmacology and chemotherapy.

[196]  R. Schreiber,et al.  Studies on the neuronal circuits involved in the discriminative stimulus effects of 5-hydroxytryptamine1A receptor agonists in the rat. , 1993, The Journal of pharmacology and experimental therapeutics.

[197]  M. Geyer,et al.  Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide , 1985, Pharmacology Biochemistry and Behavior.

[198]  J. C. Winter,et al.  Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus , 1988, Pharmacology Biochemistry and Behavior.

[199]  K. Cunningham,et al.  The use of drug discrimination procedures to characterize hallucinogenic drug actions. , 1986, Psychopharmacology bulletin.

[200]  R. Glennon,et al.  Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. , 1983, European journal of pharmacology.

[201]  R. Glennon,et al.  Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors , 1998, Psychopharmacology.

[202]  D. Sanger,et al.  Discriminative stimulus properties of 8-OH-DPAT: relationship to affinity for 5HT1A receptors , 2005, Psychopharmacology.

[203]  A. Halberstadt,et al.  Serotonin and serotonin receptors in hallucinogen action , 2020, Handbook of Behavioral Neuroscience.

[204]  Martin P Paulus,et al.  Effects of Hallucinogens on Locomotor and Investigatory Activity and Patterns: Influence of 5-HT2A and 5-HT2C Receptors , 1998, Neuropsychopharmacology.

[205]  E. sanders-Bush,et al.  Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor , 1999, Psychopharmacology.

[206]  D. Chute,et al.  Drug discrimination and state dependent learning , 1978 .

[207]  M. Kleven,et al.  Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. , 1997, The Journal of pharmacology and experimental therapeutics.

[208]  J. C. Winter,et al.  The Paradox of 5-Methoxy-N,N-Dimethyltryptamine An Indoleamine Hallucinogen That Induces Stimulus Control Via 5-HT1A Receptors , 2000, Pharmacology Biochemistry and Behavior.

[209]  R. Glennon,et al.  Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus. , 1979, Life sciences.

[210]  M. Geyer,et al.  LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor , 2009, Psychopharmacology.

[211]  E. Calcagno,et al.  Strain‐dependent serotonin neuron feedback control: role of serotonin2C receptors , 2010, Journal of neurochemistry.

[212]  M. Low,et al.  Contributions of Dopamine D1, D2, and D3 Receptor Subtypes to the Disruptive Effects of Cocaine on Prepulse Inhibition in Mice , 2008, Neuropsychopharmacology.

[213]  T. Hijzen,et al.  The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear-potentiated startle response , 1998, Psychopharmacology.

[214]  M. Geyer,et al.  Effects of DOM and DMT in a proposed animal model of hallucinogenic activity , 1985, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[215]  D. Mckenna.  Chronic treatment with (W)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain , 1989 .

[216]  L. Lanfumey,et al.  Regional Differences in the Coupling of 5-Hydroxytryptamine-1A Receptors to G Proteins in the Rat Brain , 2006, Molecular Pharmacology.

[217]  R. Reiffenstein,et al.  Direct comparison of hallucinogenic phenethylamines and D-amphetamine on dorsal raphe neurons. , 1986, European journal of pharmacology.

[218]  N. Penington.  Actions of methoxylated amphetamine hallucinogen on serotonergic neurons of the brain , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[219]  D. Grahame-Smith.  STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHAN , 1971, Journal of neurochemistry.

[220]  P. Conn,et al.  Effector systems coupled to serotonin receptors in brain: serotonin stimulated phosphoinositide hydrolysis. , 1986, Psychopharmacology bulletin.

[221]  R. Glennon,et al.  Do functional relationships exist between 5-HT1A and 5-HT2 receptors? , 1990, Pharmacology Biochemistry and Behavior.

[222]  M. Geyer,et al.  Mescaline increases startle responding equally in normal and raphe-lesioned rats , 1979, Pharmacology Biochemistry and Behavior.

[223]  J. Leysen,et al.  Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment. , 1989, European journal of pharmacology.

[224]  B. Jacobs,et al.  Dissociations between the effects of LSD on behavior and raphe unit activity in freely moving cats. , 1979, Science.

[225]  Aghajanian Gk,et al.  Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors. , 1975 .

[226]  G. Aghajanian,et al.  Response of central monoaminergic neurons to lisuride: comparison with LSD. , 1979, Life sciences.

[227]  G. Aghajanian,et al.  Effects of chlorimipramine and lysergic acid diethylamide on efflux of precursor-formed 3-H-serotonin: correlations with serotonergic impulse flow. , 1975, The Journal of pharmacology and experimental therapeutics.

[228]  D. E. Nichols,et al.  Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD). , 2002, Journal of medicinal chemistry.

[229]  S H Snyder,et al.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.

[230]  R. Glennon,et al.  Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. , 1992, Journal of medicinal chemistry.

[231]  P. Bevan.  Behavioral Pharmacology of 5-ht , 1989 .

[232]  J. Hensler,et al.  A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[233]  P. Tueting,et al.  Pharmacologic Challenge in ERP Research a , 1992, Annals of the New York Academy of Sciences.

[234]  D. Middlemiss,et al.  Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat. , 1985, European journal of pharmacology.

[235]  G. Higgins,et al.  Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs , 1995, Psychopharmacology.

[236]  H. Isbell,et al.  Observations on direct and cross tolerance with LSD and d-amphetamine in man , 1963, Psychopharmacologia.

[237]  D. Segal,et al.  Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats , 1987, Pharmacology Biochemistry and Behavior.

[238]  J. C. Winter,et al.  Psilocybin-induced stimulus control in the rat , 2007, Pharmacology Biochemistry and Behavior.

[239]  Franz X Vollenweider,et al.  Serotonin research: contributions to understanding psychoses. , 2008, Trends in pharmacological sciences.

[240]  D E Nichols,et al.  A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor. , 1998, Journal of medicinal chemistry.

[241]  H. Berendsen,et al.  Drug-induced penile erections in rats: indications of serotonin1B receptor mediation. , 1987, European journal of pharmacology.

[242]  B. Waszczak,et al.  Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5‐HT1A agonists , 1993, Synapse.

[243]  M. Geyer,et al.  The role of 5-HT(1A) receptors in the locomotor-suppressant effects of LSD: WAY-100635 studies of 8-OH-DPAT, DOI and LSD in rats. , 1996, Behavioural pharmacology.

[244]  M. Hamon,et al.  Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. , 1985, European journal of pharmacology.

[245]  J. Palacios,et al.  5-HT receptors in mammalian brain: receptor autoradiography andin situ hybridization studies of new ligands and newly identified receptors , 1996, The Histochemical Journal.

[246]  R. Schreiber,et al.  (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. , 1995, The Journal of pharmacology and experimental therapeutics.

[247]  R. Glennon.  Discriminative stimulus properties of hallucinogens and related designer drugs. , 1991, NIDA research monograph.

[248]  D. Spencer,et al.  Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine , 2004, Psychopharmacology.

[249]  P. Delgado,et al.  Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. , 2006, The Journal of clinical psychiatry.

[250]  G. Aghajanian,et al.  Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: A comparative iontophoretic study with LSD and serotonin , 1977, Neuropharmacology.

[251]  M. Geyer,et al.  Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[252]  G. Rigdon,et al.  5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. , 1992, The Journal of pharmacology and experimental therapeutics.

[253]  D. X. Freedman,et al.  Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain. , 1985, European journal of pharmacology.

[254]  P. Fletcher,et al.  Characterizing the effects of 5-HT2C receptor ligands on motor activity and feeding behaviour in 5-HT2C receptor knockout mice , 2009, Neuropharmacology.

[255]  R. Glennon,et al.  Structure-activity relationships and mechanism of action of hallucinogenic agents based on drug discrimination and radioligand binding studies. , 1986, Psychopharmacology bulletin.

[256]  E. sanders-Bush,et al.  Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice , 2005, Psychopharmacology.

[257]  R. Glennon,et al.  Further studies on the dose-dependent stimulus properties of 5-methoxy-N,N-dimethyltryptamine , 1986, Pharmacology Biochemistry and Behavior.

[258]  P. Janssen,et al.  A characterization of LSD-antagonist effects of pirenperone in the rat , 1983, Neuropharmacology.

[259]  E. Gouzoulis-Mayfrank,et al.  Blood flow and cerebral laterality in the mescaline model of psychosis. , 1998, Pharmacopsychiatry.

[260]  M. Geyer,et al.  Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice , 2011, Journal of psychopharmacology.

[261]  C. de Montigny,et al.  Differential Effect of Gepirone on Presynaptic and Postsynaptic Serotonin Receptors: Single‐Cell Recording Studies , 1990, Journal of clinical psychopharmacology.

[262]  M. Geyer,et al.  8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action , 2005, Psychopharmacology.

[263]  S. Hjorth,et al.  8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity , 1982, Journal of Neural Transmission.

[264]  D. Murphy,et al.  The serotonin 5-HT2A receptor agonist TCB-2: a behavioral and neurophysiological analysis , 2010, Psychopharmacology.

[265]  E. Gouzoulis-Mayfrank,et al.  Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers Results of an experimental double-blind placebo-controlled study , 1999, Psychopharmacology.

[266]  G. Aghajanian,et al.  Mescaline and LSD: direct and indirect effects on serotonin-containing neurons in brain. , 1973, European journal of pharmacology.

[267]  J. Leysen,et al.  Use of 5-HT Receptor Agonists and Antagonists for the Characterization of Their Respective Receptor Sites , 1989 .

[268]  T. Meert,et al.  Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats , 2004, Psychopharmacology.

[269]  Felix Hasler,et al.  Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans , 2007, Psychopharmacology.

[270]  T. Chase,et al.  Vasopressin studies in Alzheimer's disease , 1982 .

[271]  F. Colpaert,et al.  Behavioral pharmacology of antagonists at 5-HT2/5-HT1C receptors , 1992, Neuroscience & Biobehavioral Reviews.

[272]  K. Rice,et al.  Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity , 2007, Behavioural pharmacology.

[273]  E. sanders-Bush,et al.  Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors , 1998, Pharmacology Biochemistry and Behavior.

[274]  K. Heekeren,et al.  Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers , 2005, Pharmacopsychiatry.

[275]  P. Daley,et al.  Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter , 2009, Journal of Neural Transmission.

[276]  M. Jackson,et al.  The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator , 2009, Science.

[277]  B. Jacobs,et al.  Lack of tolerance to the depression of raphe unit activity by lysergic acid diethylamide , 1977, Neuropharmacology.

[278]  A. Frazer,et al.  Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists. , 1994, The Journal of pharmacology and experimental therapeutics.

[279]  M. Breeding,et al.  (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist. , 1991, The Journal of pharmacology and experimental therapeutics.

[280]  S. Peroutka,et al.  Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes , 1990, Neuropharmacology.

[281]  J. Bockaert,et al.  Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. , 1988, Molecular pharmacology.

[282]  M. Geyer,et al.  The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats , 2006, Psychopharmacology.

[283]  G. Aghajanian,et al.  Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving a serotonergic input. , 1974, The Journal of pharmacology and experimental therapeutics.

[284]  C. Sánchez,et al.  Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models. , 1996, European journal of pharmacology.

[285]  R. Godwin-Austen.  Lisuride and Other Dopamine Agonists , 1983 .

[286]  J. Hyttel,et al.  Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI. , 1989, European journal of pharmacology.

[287]  H. Isbell,et al.  The effect of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide , 1964, Psychopharmacologia.

[288]  A. Gogos,et al.  Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology , 2008, Behavioural pharmacology.

[289]  R. Glennon,et al.  Drug‐induced discrimination: A description of the paradigm and a review of its specific application to the study of hallucinogenic agents , 1983, Medicinal research reviews.

[290]  M. Geyer,et al.  DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum , 1997, Brain Research.

[291]  E. sanders-Bush,et al.  5-Hydroxytryptamine (Serotonin)2A Receptors in Rat Anterior Cingulate Cortex Mediate the Discriminative Stimulus Properties of d-Lysergic Acid Diethylamide , 2007, Journal of Pharmacology and Experimental Therapeutics.

[292]  S. Gershon,et al.  JB 329 degrees--a new spychotomimetic, its antagonism by tetrahydroaminacrin and its comparison with LSD, mescaline and sernyl. , 1960, Journal of neuropsychiatry.

[293]  T. Järbe.  LSD-25 as a discriminative stimulus for response selection by pigeons , 1980, Pharmacology Biochemistry and Behavior.

[294]  R. Glennon,et al.  N,N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin. , 1988, Journal of medicinal chemistry.

[295]  W. Pfister,et al.  An economical screen for phenethylamine-type hallucinogens: mouse ear scratching. , 1979, Communications in psychopharmacology.

[296]  D. Hoyer.  Functional correlates of serotonin 5-HT1 recognition sites. , 1988, Journal of receptor research.

[297]  D. Jackson,et al.  Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: Effects of antipsychotics and other agents in rats , 1995, Pharmacology Biochemistry and Behavior.

[298]  R. Glennon,et al.  Drug-induced cues in studying mechanisms of drug action , 1979, Neuropharmacology.

[299]  G. Aghajanian,et al.  Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors. , 1975, Psychopharmacology communications.